Artificial intelligence, drug repurposing and peer review

Research output: Contribution to journalEditorialResearchpeer-review

  • Jeremy M. Levin
  • Tudor I. Oprea
  • Sagie Davidovich
  • Thomas Clozel
  • John P. Overington
  • Quentin Vanhaelen
  • Charles R. Cantor
  • Evelyne Bischof
  • Alex Zhavoronkov

Can traditional computational analysis and machine learning help compensate for inadequate peer review of drug-repurposing papers in the context of an infodemic?

Original languageEnglish
JournalNature Biotechnology
Volume38
Pages (from-to)1127-1131
Number of pages5
ISSN1087-0156
DOIs
Publication statusPublished - 2020

    Research areas

  • COVID-19

ID: 250122352